Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Bado

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Mitochondria-nucleus communication dictates progressive versus bimodal aging of the mammary glandEdmund Charles Jenkins, Mrittika Chattopadhyay, Thelma Mashaka, et al.
Breast Cancer Research : BCR|July 5, 2017
Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesisIgor Bado, Fotis Nikolos, Gayani Rajapaksa, et al.
Science Advances|June 24, 2021
Harnessing the power of antibodies to fight bone metastasisZeru Tian, Ling Wu, Chenfei Yu, et al.
NPJ Breast Cancer|June 30, 2022
Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their researchHillary Stires, Igor Bado, Thelma Brown, et al.
Cancer Cell|November 14, 2018
The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic VulnerabilityHai Wang, Lin Tian, Jun Liu, et al.
Immunity|March 29, 2025
Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancerLiqun Yu, Keziah Liebenberg, Yichao Shen, et al.
Cancer Letters|May 30, 2026
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasisZifan Zhao, Ze-Yi Zheng, Jonathan T Lei, et al.
Nature Cell Biology|August 28, 2019
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanismsIk Sun Kim, Yang Gao, Thomas Welte, et al.
Cell Stem Cell|May 5, 2023
Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removalXiaoxin Hao, Yichao Shen, Nan Chen, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Mitochondria-nucleus communication dictates progressive versus bimodal aging of the mammary glandEdmund Charles Jenkins, Mrittika Chattopadhyay, Thelma Mashaka, et al.
Breast Cancer Research : BCR|July 5, 2017
Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesisIgor Bado, Fotis Nikolos, Gayani Rajapaksa, et al.
Science Advances|June 24, 2021
Harnessing the power of antibodies to fight bone metastasisZeru Tian, Ling Wu, Chenfei Yu, et al.
NPJ Breast Cancer|June 30, 2022
Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their researchHillary Stires, Igor Bado, Thelma Brown, et al.
Cancer Cell|November 14, 2018
The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic VulnerabilityHai Wang, Lin Tian, Jun Liu, et al.
Immunity|March 29, 2025
Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancerLiqun Yu, Keziah Liebenberg, Yichao Shen, et al.
Cancer Letters|May 30, 2026
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasisZifan Zhao, Ze-Yi Zheng, Jonathan T Lei, et al.
Nature Cell Biology|August 28, 2019
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanismsIk Sun Kim, Yang Gao, Thomas Welte, et al.
Cell Stem Cell|May 5, 2023
Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removalXiaoxin Hao, Yichao Shen, Nan Chen, et al.
Pageof 2